PBMs’ incentives to engage in exclusionary rebates warrant more scrutiny, FTC says
Concentration among pharmacy benefit managers is increasing, with vertical integration having raised various competitive concerns in the drug supply chain in the US as well as financial conflicts of interest which...To view the full article, register now.
Already a subscriber? Click here to view full article